On Monday, Wave Life Sciences Ltd (NASDAQ: WVE) opened lower -5.64% from the last session, before settling in for the closing price of $8.34. Price fluctuations for WVE have ranged from $5.04 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 34.27% over the past five years. Company’s average yearly earnings per share was noted -52.72% at the time writing. With a float of $124.26 million, this company’s outstanding shares have now reached $154.09 million.
Let’s look at the performance matrix of the company that is accounted for 288 employees. In terms of profitability, gross margin is 100.0%, operating margin of -119.83%, and the pretax margin is -107.04%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Wave Life Sciences Ltd is 20.12%, while institutional ownership is 80.74%. The most recent insider transaction that took place on Jun 13 ’25, was worth 208,500. In this transaction Director of this company sold 30,000 shares at a rate of $6.95, taking the stock ownership to the 282,517 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 30,000 for $7.20, making the entire transaction worth $216,000.
Wave Life Sciences Ltd (WVE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -52.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.70% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Check out the current performance indicators for Wave Life Sciences Ltd (WVE). In the past quarter, the stock posted a quick ratio of 2.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 2.47 million, a positive change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 71.63%.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 40.28%, which indicates a significant decrease from 65.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.51 in the past 14 days, which was lower than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.85, while its 200-day Moving Average is $10.13.
